Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 14 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 543 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RILUZOLE | 50MG | TABLET | Resolved | 2021-10-13 | 2021-10-26 | 146987 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Avoided shortage | 2021-10-13 | 2021-10-26 | 146990 |
| MYLAN-VARDENAFIL | 10MG | TABLET | Resolved | 2021-09-09 | 2021-10-26 | 145397 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Resolved | 2021-10-26 | 2021-11-17 | 148028 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-02 | 2021-11-23 | 8719 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3346 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3360 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-03 | 2021-11-23 | 8764 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2021-11-23 | 206 |
| CLARUS | 10MG | CAPSULE | Resolved | 2021-06-30 | 2021-12-21 | 141675 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2021-11-17 | 2021-12-21 | 149495 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-12-21 | 2022-01-04 | 151663 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2021-12-21 | 2022-01-04 | 151687 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-04-13 | 2022-01-12 | 6979 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-04-13 | 2022-01-12 | 6982 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-01-18 | 2022-01-26 | 152983 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 200MG 300MG | TABLET | Resolved | 2022-01-26 | 2022-02-04 | 153490 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-08-01 | 2022-02-15 | 17787 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-10-13 | 2022-02-15 | 25895 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |